Zhejiang Jolly Pharmaceutical Co.,LTD (SHE:300181)
China
· Delayed Price · Currency is CNY 15.42
+0.20 (1.31%)
Apr 29, 2026, 3:04 PM CST
SHE:300181 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 10,551 | 11,202 | 10,545 | 7,477 | 7,484 | 7,097 | Upgrade
|
| Market Cap Growth | -8.95% | 6.24% | 41.03% | -0.09% | 5.46% | 97.63% | Upgrade
|
| Enterprise Value | 10,668 | 11,238 | 10,199 | 6,742 | 7,536 | 7,203 | Upgrade
|
| Last Close Price | 15.22 | 16.16 | 14.80 | 9.98 | 9.77 | 10.41 | Upgrade
|
| PE Ratio | 16.25 | 17.73 | 20.77 | 19.52 | 27.41 | 39.56 | Upgrade
|
| Forward PE | - | 61.41 | 61.41 | 61.41 | 61.41 | 61.41 | Upgrade
|
| PS Ratio | 3.39 | 3.68 | 4.09 | 3.85 | 4.15 | 4.87 | Upgrade
|
| PB Ratio | 3.02 | 3.46 | 3.74 | 2.70 | 2.71 | 3.58 | Upgrade
|
| P/TBV Ratio | 3.74 | 3.78 | 4.11 | 2.96 | 2.98 | 4.30 | Upgrade
|
| P/FCF Ratio | 29.66 | 89.87 | 308.69 | 47.70 | 53.24 | 68.34 | Upgrade
|
| P/OCF Ratio | 18.53 | 27.20 | 35.50 | 25.92 | 23.49 | 28.18 | Upgrade
|
| EV/Sales Ratio | 3.43 | 3.70 | 3.96 | 3.47 | 4.18 | 4.94 | Upgrade
|
| EV/EBITDA Ratio | 11.81 | 12.87 | 15.51 | 13.95 | 19.92 | 25.92 | Upgrade
|
| EV/EBIT Ratio | 12.98 | 14.10 | 17.27 | 15.99 | 23.43 | 32.12 | Upgrade
|
| EV/FCF Ratio | 29.99 | 90.15 | 298.56 | 43.01 | 53.62 | 69.37 | Upgrade
|
| Debt / Equity Ratio | 0.22 | 0.21 | 0.15 | 0.08 | 0.06 | 0.10 | Upgrade
|
| Debt / EBITDA Ratio | 0.85 | 0.79 | 0.65 | 0.46 | 0.45 | 0.73 | Upgrade
|
| Debt / FCF Ratio | 2.15 | 5.55 | 12.58 | 1.42 | 1.23 | 1.99 | Upgrade
|
| Net Debt / Equity Ratio | 0.01 | 0.00 | -0.13 | -0.31 | -0.33 | -0.05 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.05 | 0.01 | -0.57 | -1.78 | -2.43 | -0.33 | Upgrade
|
| Net Debt / FCF Ratio | 0.14 | 0.09 | -10.98 | -5.49 | -6.54 | -0.88 | Upgrade
|
| Asset Turnover | 0.63 | 0.70 | 0.68 | 0.53 | 0.56 | 0.56 | Upgrade
|
| Inventory Turnover | 2.25 | 2.21 | 2.14 | 1.65 | 1.81 | 1.77 | Upgrade
|
| Quick Ratio | 1.19 | 1.37 | 1.52 | 2.04 | 2.16 | 1.13 | Upgrade
|
| Current Ratio | 1.55 | 1.79 | 2.06 | 2.59 | 2.60 | 1.61 | Upgrade
|
| Return on Equity (ROE) | 19.81% | 21.20% | 18.45% | 14.12% | 12.04% | 10.37% | Upgrade
|
| Return on Assets (ROA) | 10.37% | 11.45% | 9.69% | 7.25% | 6.29% | 5.37% | Upgrade
|
| Return on Invested Capital (ROIC) | 20.51% | 23.79% | 23.44% | 19.66% | 15.19% | 10.63% | Upgrade
|
| Return on Capital Employed (ROCE) | 22.50% | 23.60% | 20.10% | 14.90% | 11.10% | 10.40% | Upgrade
|
| Earnings Yield | 6.16% | 5.64% | 4.82% | 5.12% | 3.65% | 2.53% | Upgrade
|
| FCF Yield | 3.37% | 1.11% | 0.32% | 2.10% | 1.88% | 1.46% | Upgrade
|
| Dividend Yield | 3.89% | - | 4.05% | 4.51% | 3.07% | 1.92% | Upgrade
|
| Payout Ratio | 64.17% | 67.08% | 63.18% | 55.65% | 53.17% | 39.17% | Upgrade
|
| Buyback Yield / Dilution | 0.16% | 0.17% | 0.10% | -14.76% | 1.93% | -1.64% | Upgrade
|
| Total Shareholder Return | 4.04% | 0.17% | 4.15% | -10.25% | 5.01% | 0.28% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.